• OPEN AN ACCOUNT
Indian Indices
Nifty
26,192.15 139.50
(0.54%)
Sensex
85,632.68 446.21
( 0.52%)
Bank Nifty
59,347.70 131.65
( 0.22%)
Nifty IT
37,043.30 -1.35
( 0.00%)
Global Indices
Nasdaq
46,147.42 34.67
(0.08%)
Dow Jones
6,662.03 23.71
(0.36%)
Hang Seng
49,837.83 1,300.13
(2.68%)
Nikkei 225
9,572.31 64.90
(0.68%)
Forex
USD-INR
88.58 -0.05
(-0.06%)
EUR-INR
102.64 -0.14
(-0.14%)
GBP-INR
116.49 -0.15
(-0.13%)
JPY-INR
0.57 0.00
(-0.31%)

EQUITY - MARKET SCREENER

BDH Industries Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524828
INE278D01018
120.3098958
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
23.37
227.81
EPS(TTM)
Face Value()
Div & Yield %
16.92
10
1.14
 

tiaan consumer ltd
HFCL Ltd - Un-Audited Financial Results Of The Company For The 2Nd Quarter And Half Year Ended September 30 2025 Of The Financial Year 2025-26 Both On Standalone And Consolidated
Oct 17,2025
This is in continuation to our earlier intimation dated October 09 2025 with respect to the meeting of the Board of Directors of the Company scheduled on October 17 2025. In terms of Regulation 30 read with Part A of Schedule III of the SEBI Listing Regulations we would like to inform all our stakeholders that the Board of Directors at its meeting held today has inter-alia considered and approved the Un-audited Financial Results of the Company for the 2nd Quarter and Half Year ended September 30 2025 of the Financial Year 2025-26 both on Standalone and Consolidated basis (Financial Results) in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations along with the Limited Review Report of the Auditors thereon duly reviewed and recommended by the Audit Committee in its meeting held today.